Skip to main content
Premium Trial:

Request an Annual Quote

Isabelle Guyon

Premium

Health Discovery Corp. (formerly Direct Wireless Communications) last week appointed Isabelle Guyon, a former neural network specialist at AT&T Bell Laboratories, to its scientific advisory board. Guyon, an expert in statistical data analysis, pattern recognition, and machine learning, is vice president of the International Unipen Foundation, which oversees a large-scale database of handwritten samples for use in handwriting recognition research. Through her consulting firm Clopinet, Guyon has developed data analysis methods for genomics and proteomics applications in biomarker discovery, among other projects.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.